2023 Form 5500 filing — Octave Bioscience 401(K) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241009121714NAL0037715970001) for Octave Bioscience 401(K) Plan, reported by Octave Bioscience, Inc. under EIN 47-2289700 and plan number 001. It reports 62 participants. Attached schedules in the loaded dataset include Schedule I (small plan financials).

Form 5500 2 · 2023

Filing snapshot

Net assets (EOY)$3.7MReported net assets$3,745,236
Participants62
Provider compensationNone reported
Schedules filedSchedule ILoaded schedules
EFAST2 acknowledgement
20241009121714NAL0037715970001
Plan sponsor
Octave Bioscience, Inc.
EIN
47-2289700
Plan number
001
Location
Menlo Park, CA
Received date
not reported in the loaded dataset
How to read this filing
  • This is a single annual Form 5500 filing, identified by its EFAST2 acknowledgement id.
  • Schedule chips (Sch H / I / C) show which schedules this filing includes.
  • Net assets = total assets minus total liabilities (Schedule H/I).
  • Fields a filing did not report are labeled not reported in the loaded dataset — never estimated.
  • For the plan's full history, open the plan profile.
Schedule I · 2023

Reported financial snapshot

Reported figures as filed, in whole dollars. Only fields the filing reports are shown.

Reported balance (end of year)$3.7M total assets
Net assets$3.7MLiabilities$0
Money in vs. money out
Total income / additions$2.1M
Total expenses$517.8K
Benefits paid / distributions$523.2K
Contributions
Employer$0
Participant$1M
Full reported line items
Total assets (EOY)
$3,745,236
Total liabilities (EOY)
$0
Net assets (EOY)
$3,745,236
Employer contributions
$0
Participant contributions
$1,035,941
Total income / additions
$2,067,082
Benefits paid
$523,226
Administrative expenses
-$8,272
Total expenses
$517,842
Net increase / (decrease)
$1,549,240

What to inspect next

Frequently asked questions

What does EFAST2 acknowledgement 20241009121714NAL0037715970001 cover?
It is the 2023 Form 5500 filing for Octave Bioscience 401(K) Plan, reported by Octave Bioscience, Inc. (EIN 47-2289700).
Which Form 5500 schedules are attached to this 2023 filing?
Attached schedules in the loaded dataset include Schedule I (small plan financials).

Related Form 5500 pages